221 related articles for article (PubMed ID: 31734819)
1. Predictive performance of lipid accumulation product and visceral adiposity index for renal function decline in non-diabetic adults, an 8.6-year follow-up.
Mousapour P; Barzin M; Valizadeh M; Mahdavi M; Azizi F; Hosseinpanah F
Clin Exp Nephrol; 2020 Mar; 24(3):225-234. PubMed ID: 31734819
[TBL] [Abstract][Full Text] [Related]
2. Visceral Adiposity Index and Lipid Accumulation Product Index: Two Alternate Body Indices to Identify Chronic Kidney Disease among the Rural Population in Northeast China.
Dai D; Chang Y; Chen Y; Chen S; Yu S; Guo X; Sun Y
Int J Environ Res Public Health; 2016 Dec; 13(12):. PubMed ID: 27983609
[TBL] [Abstract][Full Text] [Related]
3. Lipid accumulation product, visceral adiposity index and risk of chronic kidney disease.
Bullen AL; Katz R; Kumar U; Gutierrez OM; Sarnak MJ; Kramer HJ; Shlipak MG; Ix JH; Judd SE; Cushman M; Garimella PS
BMC Nephrol; 2022 Dec; 23(1):401. PubMed ID: 36522626
[TBL] [Abstract][Full Text] [Related]
4. Lipid accumulation product and visceral adiposity ındex: two new indices to predict metabolic syndrome in chronic kidney disease.
Biyik Z; Guney I
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2167-2173. PubMed ID: 30915762
[TBL] [Abstract][Full Text] [Related]
5. Association of lipid accumulation product and visceral adiposity index with the risk of hypertension among oil workers in Xinjiang, China.
Muheiyati G; Mei Y; Tao N
PeerJ; 2023; 11():e15273. PubMed ID: 37214102
[TBL] [Abstract][Full Text] [Related]
6. Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study.
Bozorgmanesh M; Hadaegh F; Azizi F
Lipids Health Dis; 2010 May; 9():45. PubMed ID: 20459710
[TBL] [Abstract][Full Text] [Related]
7. Gender difference in the association of chronic kidney disease with visceral adiposity index and lipid accumulation product index in Korean adults: Korean National Health and Nutrition Examination Survey.
Seong JM; Lee JH; Gi MY; Son YH; Moon AE; Park CE; Sung HH; Yoon H
Int Urol Nephrol; 2021 Jul; 53(7):1417-1425. PubMed ID: 33389514
[TBL] [Abstract][Full Text] [Related]
8. SUITABILITY OF VISCERAL ADIPOSITY INDEX AS A MARKER FOR CARDIOMETABOLIC RISKS IN JORDANIAN ADULTS.
Numan Ahmad M; Halim Haddad F
Nutr Hosp; 2015 Dec; 32(6):2701-9. PubMed ID: 26667723
[TBL] [Abstract][Full Text] [Related]
9. Are visceral adiposity index and lipid accumulation product reliable indices for metabolic disturbances in patients with type 2 diabetes mellitus?
Kavaric N; Klisic A; Ninic A
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28632304
[TBL] [Abstract][Full Text] [Related]
10. Association of Visceral Obesity Indices With Incident Diabetic Retinopathy in Patients With Diabetes: Prospective Cohort Study.
Chen J; Li YT; Niu Z; He Z; Xie YJ; Hernandez J; Huang W; Wang HHX;
JMIR Public Health Surveill; 2024 Feb; 10():e48120. PubMed ID: 38319705
[TBL] [Abstract][Full Text] [Related]
11. Lipid accumulation product and incident cardiovascular events in a normal weight population: Tehran Lipid and Glucose Study.
Hosseinpanah F; Barzin M; Mirbolouk M; Abtahi H; Cheraghi L; Azizi F
Eur J Prev Cardiol; 2016 Jan; 23(2):187-93. PubMed ID: 25381336
[TBL] [Abstract][Full Text] [Related]
12. Lipid accumulation product and visceral adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype.
Du T; Yu X; Zhang J; Sun X
Acta Diabetol; 2015 Oct; 52(5):855-63. PubMed ID: 25690647
[TBL] [Abstract][Full Text] [Related]
13. Visceral, general, abdominal adiposity and atherogenic index of plasma in relatively lean hemodialysis patients.
Zhou C; Peng H; Yuan J; Lin X; Zha Y; Chen H
BMC Nephrol; 2018 Aug; 19(1):206. PubMed ID: 30115010
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Syndrome and Obesity-Related Indices Are Associated with Rapid Renal Function Decline in a Large Taiwanese Population Follow-Up Study.
Su WY; Chen IH; Gau YC; Wu PY; Huang JC; Tsai YC; Chen SC; Chang JM; Hwang SJ; Chen HC
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885048
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the complex "Visceral Adiposity Index" vs. simple anthropometric measures: Tehran lipid and glucose study.
Mohammadreza B; Farzad H; Davoud K; Fereidoun Prof AF
Cardiovasc Diabetol; 2012 Mar; 11():20. PubMed ID: 22394430
[TBL] [Abstract][Full Text] [Related]
16. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome.
Anik Ilhan G; Yildizhan B; Pekin T
Gynecol Endocrinol; 2019 Mar; 35(3):233-236. PubMed ID: 30303693
[TBL] [Abstract][Full Text] [Related]
17. Children's Lipid Accumulation Product Combining Visceral Adiposity Index is a Novel Indicator for Predicting Unhealthy Metabolic Phenotype Among Chinese Children and Adolescents.
Dong Y; Bai L; Cai R; Zhou J; Ding W
Diabetes Metab Syndr Obes; 2021; 14():4579-4587. PubMed ID: 34848982
[TBL] [Abstract][Full Text] [Related]
18. Visceral adiposity index and lipid accumulation product as a predictor of type 2 diabetes mellitus: The Bogor cohort study of non-communicable diseases risk factors.
Nusrianto R; Ayundini G; Kristanti M; Astrella C; Amalina N; Muhadi ; Riyadina W; Tahapary DL; Soewondo P
Diabetes Res Clin Pract; 2019 Sep; 155():107798. PubMed ID: 31330161
[TBL] [Abstract][Full Text] [Related]
19. Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance.
Mazidi M; Kengne AP; Katsiki N; Mikhailidis DP; Banach M
J Diabetes Complications; 2018 Mar; 32(3):266-270. PubMed ID: 29395839
[TBL] [Abstract][Full Text] [Related]
20. Lipid accumulation product and visceral adiposity index: two indices to predict metabolic syndrome and insulin resistance in chronic kidney disease patients.
Fahmy AM; El Shall N; Kabbash I; El Ahwal L; Selim A
Endocr Regul; 2023 Jan; 57(1):99-105. PubMed ID: 37183690
[No Abstract] [Full Text] [Related]
[Next] [New Search]
